Who is Pharma Going to Blame When PBMs are Gone and Drug Prices are Still Crazy?
The pharmaceutical industry, who make our drugs (good) and then set outlandish prices for them (bad), has developed a unique logic to blame PBMs (Pharmacy Benefit Managers - the people whose job it is to negotiate lower prices for consumers) for the higher price of drugs.
Hospital Chargemasters Leading to Confused Patients, Questions About Costs
A new federal law praised for what some considered a giant leap toward increased healthcare transparency may be making an already-confusing experience even more confusing. The rule effective Jan. 1 requires hospitals to publicize prices online for any services they offer. Unfortunately for patients, early reports on the process have not been favorable.
Generic Insulin Could Lower Costs, but Red Tape and Prescribing Habits Won’t Make It Easy
Imagine you spend years fine-tuning formulas and undergoing tests, trials, and experiments, before finally developing a potentially life-saving drug. And then two of your neighbors do the same. Over the next century or so, the three of you control the overwhelming majority of the market for that drug, raising prices as you wish and leaving little room for competition or a generic alternative.
Big Pharma Balks at Lowering Own Prices in Response to Rising Drug Costs
Leadership from seven different drug makers appeared before the Senate Finance Committee late last month , to provide their recommendations for solving the crisis surrounding drug costs. The executives from AbbVie, AstraZeneca, Bristol-Myers Squibb, Johnson & Johnson, Merck, Pfizer, and Sanofi presented an assortment of ideas that were heavy on finger-pointing and light on actionable solutions.
Thoughts on the big news from Blue Cross NC
A few hours ago, the North Carolina healthcare landscape received some interesting news. Our largest insurer, Blue Cross NC, has announced that they are going to enter into an affiliation with another company (Cambia, which manages several Blue Cross plans) based outside of North Carolina.
Blue Cross NC Funding Mobile Health Units Through $750,000 Contribution to ONE Charlotte
In the wake of the civil unrest that enveloped the city of Charlotte in 2016, a directive called ONE Charlotte formed through a partnership between Atrium Health, Novant Health and Bank of America. That collaboration intended to serve critical challenges the community would face, including removing barriers to education, employment, and healthcare.